Files
Abstract
Gabapentin is an antiepileptic drug (AED) commonly used in the treatment of bipolar disorder (BPD). In 2008, the US Food and Drug Administration (FDA) concluded that it is associated with an increased risk of suicidality; however, published studies have arrived at conflicting conclusions. The objective of this work is to assess the association between the use of gabapentin and suicidality in a cohort of adult patients diagnosed with bipolar disorder (BPD), and to determine if the risk is greater relative to patients prescribed lithium.